From: A pilot randomized controlled trial of pioglitazone for the treatment of poorly controlled asthma in obesity
placebo
pioglitazone
P-value*
PC20 at baseline (mg/ml)
1.99 (3.08)
1.60 (5.91)
n = 11
n = 12
PC20 at 12Â weeks (mg/ml)
2.37 (15.22)
5.08 (7.42)
n = 9
n = 10
0.38